Anke Verlinden

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille, Ann L. Van de Velde, Evelien Smits et al. · Blood · 2017 · 228 citations · Full text

Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience

Anke Verlinden, Hilde Jansens, Herman Goossens et al. · Open Forum Infectious Diseases · 2021 · 46 citations · Full text

Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia

Anke Verlinden, Hilde Jansens, Herman Goossens et al. · European Journal Of Haematology · 2014 · 34 citations

Determining factors predictive of CD34+ cell collection efficiency in an effort to avoid extended and repeated apheresis sessions

Anke Verlinden, Ann Van de Velde, Gert A. Verpooten et al. · Journal of Clinical Apheresis · 2013 · 23 citations

Passenger Lymphocyte Syndrome (PLS): A Single-center Retrospective Analysis of Minor ABO-incompatible Liver Transplants

Sévérine de Bruijn, Ester Philipse, Marie M. Couttenye et al. · Journal of Clinical and Translational Hepatology · 2017 · 20 citations · Full text